Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nature Reviews Bioengineering is Scopus-indexed (Q1, CiteScore 40.3), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer Nature.
Checked against the index lists dated .
ISSN 2731-6092Verify ISSN ↗
Publisher: Springer Nature
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biophysics | 1 / 155 | 99th | Q1 |
| Biomedical Engineering | 4 / 342 | 98th | Q1 |
| Applied Microbiology and Biotechnology | 2 / 134 | 98th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2023–present, best quartile Q1, CiteScore 40.3.
Nature Reviews Bioengineering is Q1 in Biophysics (rank 1 of 155), Q1 in Biomedical Engineering (rank 4 of 342) and Q1 in Applied Microbiology and Biotechnology (rank 2 of 134), by CiteScore 2025.
Nature Reviews Bioengineering is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 40.3, which places it in quartile Q1 at the 99th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 9.178, quartile Q1, with an H-index of 44.
Nature Reviews Bioengineering is published by Springer Nature. Its ISSN is 2731-6092.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Nature Reviews Bioengineering has an h-index of 67 and a 2-year mean of 19.51 citations per paper (OpenAlex). Its Scopus CiteScore is 40.3, quartile Q1. On 2-year citations it ranks #1 of 154 Scopus journals in Biophysics.
Nature Reviews Bioengineering published 124 papers in 2025; its busiest recent year was 2023 with 145. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 81 research articles (2026), authors are most often from United States (40%), Australia (7.9%) and China (7.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.